• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性淋巴结转移性前列腺癌伴血清前列腺特异性抗原水平降低的自发缓解

The Spontaneous Remission of Recurrent Lymph Node Metastatic Prostate Cancer With Lowering Serum Prostate-Specific Antigen Level.

作者信息

Katano Atsuto, Minamitani Masanari, Nakagawa Keiichi, Yamashita Hideomi

机构信息

Radiology, The University of Tokyo Hospital, Tokyo, JPN.

Radiation Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, JPN.

出版信息

Cureus. 2022 May 25;14(5):e25333. doi: 10.7759/cureus.25333. eCollection 2022 May.

DOI:10.7759/cureus.25333
PMID:35774690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9236640/
Abstract

The incidence rate of spontaneous remission of malignant cancer is very low. Reports on spontaneous remission in advanced prostate cancer are extremely limited. Our patient was treated with androgen deprivation therapy, local radiotherapy, and surgical castration at the initial diagnosis. Approximately nine years after treatment, he experienced a rise in serum prostate-specific antigen level and relapse of obturator lymph node adenopathy. Initially, androgen deprivation therapy was reinitiated, which resulted in castration-resistant prostate cancer. Although androgen deprivation therapy was discontinued, spontaneous remission of recurrent lymph node and spontaneous reduction in serum prostate-specific antigen level was seen. There was no sign of radiological recurrence for over eight years without prostate cancer treatment.

摘要

恶性肿瘤的自发缓解率非常低。关于晚期前列腺癌自发缓解的报道极为有限。我们的患者在初诊时接受了雄激素剥夺治疗、局部放疗和手术去势。治疗后约九年,他的血清前列腺特异性抗原水平升高,闭孔淋巴结病复发。最初重新开始雄激素剥夺治疗,导致了去势抵抗性前列腺癌。尽管停止了雄激素剥夺治疗,但仍出现了复发性淋巴结的自发缓解以及血清前列腺特异性抗原水平的自发降低。在未进行前列腺癌治疗的情况下,超过八年没有影像学复发的迹象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6550/9236640/9b18e571cb98/cureus-0014-00000025333-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6550/9236640/d39385e72e18/cureus-0014-00000025333-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6550/9236640/2c5510f283be/cureus-0014-00000025333-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6550/9236640/0a7f43e8e863/cureus-0014-00000025333-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6550/9236640/9b18e571cb98/cureus-0014-00000025333-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6550/9236640/d39385e72e18/cureus-0014-00000025333-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6550/9236640/2c5510f283be/cureus-0014-00000025333-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6550/9236640/0a7f43e8e863/cureus-0014-00000025333-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6550/9236640/9b18e571cb98/cureus-0014-00000025333-i04.jpg

相似文献

1
The Spontaneous Remission of Recurrent Lymph Node Metastatic Prostate Cancer With Lowering Serum Prostate-Specific Antigen Level.复发性淋巴结转移性前列腺癌伴血清前列腺特异性抗原水平降低的自发缓解
Cureus. 2022 May 25;14(5):e25333. doi: 10.7759/cureus.25333. eCollection 2022 May.
2
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分:晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
3
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought.根治性前列腺切除术后前列腺癌淋巴结复发行挽救性淋巴结清扫术的长期疗效:并不如先前认为的那样好。
Eur Urol. 2020 Nov;78(5):661-669. doi: 10.1016/j.eururo.2020.06.043. Epub 2020 Jul 2.
4
Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study.醋酸阿比特龙联合泼尼松治疗一线去势治疗失败的转移性去势抵抗性前列腺癌患者的疗效和安全性:一项单臂、4 期研究。
Jpn J Clin Oncol. 2021 Apr 1;51(4):544-551. doi: 10.1093/jjco/hyaa225.
5
Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses.转移性去势敏感性前列腺癌中依泽替米贝联合雄激素剥夺治疗的疗效:ARCHES 事后分析。
J Urol. 2021 May;205(5):1361-1371. doi: 10.1097/JU.0000000000001568. Epub 2020 Dec 28.
6
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.EAU-ESTRO-SIOG 前列腺癌诊治指南。第二部分:复发、转移和去势抵抗性前列腺癌的治疗。
Eur Urol. 2017 Apr;71(4):630-642. doi: 10.1016/j.eururo.2016.08.002. Epub 2016 Aug 31.
7
Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the Literature.前列腺癌初次局部治疗后仅淋巴结复发的管理:文献系统综述
J Urol. 2015 Oct;194(4):983-8. doi: 10.1016/j.juro.2015.04.103. Epub 2015 May 9.
8
Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer.在一名转移性前列腺癌患者中,先前使用非甾体类抗雄激素药物未能预防促黄体生成素释放激素激动剂引发的病情 flare-up。 (注:这里“flare-up”直译为“病情突然加重”,但在医学语境中,可能有更专业的术语表述,需结合具体医学知识进一步确定其准确含义)
BMC Res Notes. 2015 Aug 5;8:335. doi: 10.1186/s13104-015-1297-3.
9
Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean Cancer Study of the Prostate risk classification.接受原发性雄激素剥夺治疗的前列腺癌患者的简单风险评估:韩国前列腺癌风险分类研究
Int J Urol. 2019 Jan;26(1):62-68. doi: 10.1111/iju.13800. Epub 2018 Sep 20.
10
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial.局部消融、影像引导放疗在镓-68前列腺特异性膜抗原靶向正电子发射断层扫描分期的去势敏感性寡转移前列腺癌中的毒性和疗效:OLI-P 2期临床试验
Eur Urol Oncol. 2022 Feb;5(1):44-51. doi: 10.1016/j.euo.2021.10.002. Epub 2021 Nov 14.

本文引用的文献

1
Highlighting Immune System and Stress in Major Depressive Disorder, Parkinson's, and Alzheimer's Diseases, with a Connection with Serotonin.强调免疫系统和压力在重度抑郁症、帕金森病和阿尔茨海默病中的作用,以及它们与血清素的关系。
Int J Mol Sci. 2021 Aug 7;22(16):8525. doi: 10.3390/ijms22168525.
2
The spontaneous remission of cancer: Current insights and therapeutic significance.癌症的自发缓解:当前见解与治疗意义。
Transl Oncol. 2021 Sep;14(9):101166. doi: 10.1016/j.tranon.2021.101166. Epub 2021 Jul 6.
3
Spontaneous Regression of Small Cell Lung Carcinoma and Associated Hemichorea.
小细胞肺癌自发消退及相关偏侧舞动症。
Intern Med. 2021 Dec 1;60(23):3817-3821. doi: 10.2169/internalmedicine.7190-21. Epub 2021 Jun 19.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer.8q24 遗传变异与综合单体型改变前列腺癌家族发病风险。
Nat Commun. 2020 Mar 23;11(1):1523. doi: 10.1038/s41467-020-15122-1.
6
Major surgery induces acute changes in measured DNA methylation associated with immune response pathways.大手术会引起与免疫反应途径相关的已测量 DNA 甲基化的急性变化。
Sci Rep. 2020 Apr 1;10(1):5743. doi: 10.1038/s41598-020-62262-x.
7
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study.男性 BRCA1 和 BRCA2 基因突变携带者的前列腺癌风险:一项前瞻性队列研究。
Eur Urol. 2020 Jan;77(1):24-35. doi: 10.1016/j.eururo.2019.08.025. Epub 2019 Sep 6.
8
The Epidemiology of Prostate Cancer.前列腺癌的流行病学。
Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):a030361. doi: 10.1101/cshperspect.a030361.
9
Current treatment strategies for advanced prostate cancer.晚期前列腺癌的当前治疗策略。
Int J Urol. 2018 Mar;25(3):220-231. doi: 10.1111/iju.13512. Epub 2017 Dec 20.
10
Case: Spontaneous regression of post-radical prostatectomy prostate-specific antigen elevation without adjuvant therapy in a patient with lymph node metastasis.病例:一名有淋巴结转移的患者在根治性前列腺切除术后前列腺特异性抗原升高,未经辅助治疗而自发消退。
Can Urol Assoc J. 2017 Jul;11(7):E315-E317. doi: 10.5489/cuaj.4324. Epub 2017 Jul 11.